Future of Treatment for Low-Risk Prostate Cancer: For All, for Some, or for None?
Author:
Affiliation:
1. Brigham and Women's Hospital and Dana Farber Cancer Institute, Boston, MA
Publisher
American Society of Clinical Oncology (ASCO)
Subject
Cancer Research,Oncology
Link
http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2010.34.2006
Reference37 articles.
1. Screening and Prostate-Cancer Mortality in a Randomized European Study
2. Mortality results from the Göteborg randomised population-based prostate-cancer screening trial
3. Mortality Results from a Randomized Prostate-Cancer Screening Trial
4. Comorbidity and Mortality Results From a Randomized Prostate Cancer Screening Trial
5. Five-year Outcome of Stereotactic Hypofractionated Accurate Radiotherapy of the Prostate (SHARP) for Patients with Low-risk Prostate Cancer
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. High-quality Linac-based Stereotactic Body Radiation Therapy with Flattening Filter Free Beams and Volumetric Modulated Arc Therapy for Low–Intermediate Risk Prostate Cancer. A Mono-institutional Experience with 90 Patients;Clinical Oncology;2016-12
2. Five-year outcomes after iodine-125 seed brachytherapy for low-risk prostate cancer at three cancer centres in the UK;BJU International;2013-12-02
3. Patient Selection and Recommendations on Permanent Seed Implantation as Monotherapy for Localized Prostate Cancer;Interstitial Prostate Brachytherapy;2013
4. The More Things Change, the More They Stay the Same—Or Do They?;Oncology Nursing Forum;2012-12-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3